TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free RNAZ Stock Alerts $0.74 +0.12 (+20.09%) (As of 12:58 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TransCode Therapeutics Stock Price Performance5 Day Performance-44.36%1 Month Performance+19.11%3 Month Performance+5.73%6 Month Performance-94.16%Year-To-Date Performance-88.77%1 Year Performance-99.69% Receive RNAZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceHow to Make 100X on the AI BoomFor over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs RNAZ Stock Chart for Tuesday, May, 14, 2024 RNAZ Chart by TradingView TransCode Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$1.41$0.62-56.30%$1.15$0.556.94 million shs$3.77 million05/10/2024$1.33$1.41+6.02%$2.01$1.3513.24 million shs$8.62 million05/09/2024$1.02$1.33+30.39%$1.39$0.983.23 million shs$8.13 million05/08/2024$1.16$1.02-12.07%$1.10$0.922.03 million shs$6.23 million05/07/2024$0.81$1.16+42.38%$1.20$0.814.88 million shs$7.09 million05/06/2024$0.82$0.81-0.65%$0.88$0.801.05 million shs$4.98 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$0.71$0.82+15.98%$1.05$0.706.05 million shs$5.01 million05/02/2024$0.63$0.71+12.26%$0.79$0.631.86 million shs$4.32 million05/01/2024$0.61$0.63+3.74%$0.64$0.59413,056 shs$3.53 million04/30/2024$0.60$0.61+1.79%$0.62$0.56493,848 shs$3.53 million04/29/2024$0.55$0.60+8.46%$0.63$0.531.17 million shs$3.47 million04/26/2024$0.53$0.55+4.74%$0.58$0.50711,173 shs$3.20 million04/25/2024$0.44$0.53+19.35%$0.54$0.441.24 million shs$3.05 million04/24/2024$0.46$0.44-4.35%$0.47$0.4291,180 shs$2.56 million04/23/2024$0.46$0.46+0.20%$0.47$0.45101,044 shs$2.67 million04/22/2024$0.49$0.46-5.36%$0.49$0.42278,389 shs$2.67 million04/19/2024$0.50$0.49-3.39%$0.50$0.48112,982 shs$2.82 million04/18/2024$0.50$0.50+0.10%$0.52$0.48406,090 shs$2.92 million04/17/2024$0.51$0.50-0.69%$0.54$0.48309,841 shs$2.91 million04/16/2024$0.54$0.51-5.84%$0.53$0.47423,662 shs$2.93 million04/15/2024$0.62$0.54-13.68%$0.66$0.503.53 million shs$3.12 million04/12/2024$0.64$0.62-2.81%$0.64$0.61114,088 shs$391,000.0004/11/2024$0.64$0.64+0.51%$0.65$0.60115,848 shs$403,000.0004/10/2024$0.64$0.64-0.66%$0.67$0.6471,733 shs$401,000.0004/09/2024$0.66$0.64-2.26%$0.66$0.6482,825 shs$403,000.0004/08/2024$0.64$0.66+2.34%$0.66$0.6461,613 shs$411,000.0004/05/2024$0.68$0.64-5.87%$0.67$0.6492,339 shs$403,000.0004/04/2024$0.65$0.68+4.60%$0.69$0.6556,460 shs$428,000.0004/03/2024$0.68$0.65-4.71%$0.69$0.65171,070 shs$410,000.0004/02/2024$0.69$0.68-1.43%$0.70$0.66233,141 shs$430,000.0004/01/2024$0.68$0.69+1.32%$0.71$0.66163,778 shs$436,000.0003/29/2024$0.68$0.68+0.98%$0.68$0.62248,176 shs$430,000.0003/28/2024$0.68$0.68-0.37%$0.68$0.62248,159 shs$426,000.0003/27/2024$0.66$0.68+2.88%$0.68$0.63157,733 shs$428,000.0003/26/2024$0.68$0.66-2.66%$0.68$0.6388,825 shs$416,000.0003/25/2024$0.67$0.68+1.74%$0.69$0.6682,917 shs$427,000.0003/22/2024$0.68$0.67-2.30%$0.68$0.6573,626 shs$420,000.0003/21/2024$0.70$0.68-2.57%$0.70$0.62170,343 shs$430,000.0003/20/2024$0.68$0.70+2.76%$0.72$0.67313,452 shs$441,000.0003/19/2024$0.68$0.68+0.71%$0.70$0.65135,207 shs$427,000.00Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here.03/18/2024$0.69$0.68-2.11%$0.70$0.61150,539 shs$426,000.0003/15/2024$0.69$0.69+0.16%$0.70$0.67140,245 shs$435,000.0003/14/2024$0.65$0.69+6.14%$0.70$0.65236,692 shs$433,000.0003/13/2024$0.60$0.65+9.24%$0.66$0.60218,980 shs$410,000.0003/12/2024$0.64$0.60-6.87%$0.63$0.57532,380 shs$375,000.0003/11/2024$0.70$0.64-8.60%$0.72$0.631.33 million shs$403,000.0003/08/2024$0.73$0.69-5.34%$0.73$0.68347,845 shs$435,000.0003/07/2024$0.70$0.73+4.29%$0.73$0.70303,730 shs$460,000.0003/06/2024$0.69$0.70+1.87%$0.72$0.68322,636 shs$441,000.0003/05/2024$0.70$0.69-1.84%$0.71$0.68133,540 shs$433,000.0003/04/2024$0.72$0.70-2.78%$0.73$0.70190,661 shs$441,000.0003/01/2024$0.70$0.72+2.19%$0.74$0.70312,119 shs$454,000.0002/29/2024$0.70$0.70+1.22%$0.71$0.68378,976 shs$442,000.0002/28/2024$0.71$0.70-1.81%$0.71$0.69202,182 shs$439,000.0002/27/2024$0.71$0.71-0.18%$0.72$0.69430,571 shs$447,000.0002/26/2024$0.69$0.71+3.30%$0.74$0.69861,032 shs$447,000.0002/23/2024$0.73$0.69-4.96%$0.72$0.67219,143 shs$435,000.0002/22/2024$0.67$0.73+8.36%$0.73$0.65447,434 shs$457,000.0002/21/2024$0.68$0.67-1.33%$0.69$0.64260,356 shs$422,000.0002/20/2024$0.68$0.68$0.69$0.66499,771 shs$428,000.0002/19/2024$0.68$0.68$0.69$0.63168,400 shs$426,000.0002/16/2024$0.66$0.68+2.88%$0.69$0.63159,092 shs$428,000.0002/15/2024$0.70$0.66-5.70%$0.72$0.61695,046 shs$414,000.0002/14/2024$0.70$0.70$0.74$0.65538,793 shs$441,000.0002/13/2024$0.71$0.70-1.14%$0.70$0.65362,014 shs$441,000.00 Related Companies: Processa Pharmaceuticals Stock Chart iBio Stock Chart Shuttle Pharmaceuticals Stock Chart Tenax Therapeutics Stock Chart Pulmatrix Stock Chart Can-Fite BioPharma Stock Chart Pasithea Therapeutics Stock Chart Universe Pharmaceuticals Stock Chart ASLAN Pharmaceuticals Stock Chart Ainos Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.